| Year |
Citation |
Score |
| 2019 |
Hart MP. Stress-Induced Neuron Remodeling Reveals Differential Interplay Between Neurexin and Environmental Factors in . Genetics. PMID 31558583 DOI: 10.1534/genetics.119.302415 |
0.33 |
|
| 2018 |
Hart MP, Hobert O. Neurexin controls plasticity of a mature, sexually dimorphic neuron. Nature. 553: 165-170. PMID 29323291 DOI: 10.1038/Nature25192 |
0.326 |
|
| 2017 |
Kerk SY, Kratsios P, Hart M, Mourao R, Hobert O. Diversification of C. elegans Motor Neuron Identity via Selective Effector Gene Repression. Neuron. 93: 80-98. PMID 28056346 DOI: 10.1016/J.Neuron.2016.11.036 |
0.372 |
|
| 2015 |
Coyne AN, Yamada SB, Siddegowda BB, Estes PS, Zaepfel BL, Johannesmeyer JS, Lockwood DB, Pham LT, Hart MP, Cassel JA, Freibaum B, Boehringer AV, Taylor JP, Reitz AB, Gitler AD, et al. Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation. Human Molecular Genetics. PMID 26385636 DOI: 10.1093/Hmg/Ddv389 |
0.77 |
|
| 2012 |
Hart MP, Gitler AD. ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 9133-42. PMID 22764223 DOI: 10.1523/Jneurosci.0996-12.2012 |
0.734 |
|
| 2012 |
Hart MP, Brettschneider J, Lee VM, Trojanowski JQ, Gitler AD. Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions. Acta Neuropathologica. 124: 221-30. PMID 22526021 DOI: 10.1007/S00401-012-0985-5 |
0.752 |
|
| 2012 |
Couthouis J, Hart MP, Erion R, King OD, Diaz Z, Nakaya T, Ibrahim F, Kim HJ, Mojsilovic-Petrovic J, Panossian S, Kim CE, Frackelton EC, Solski JA, Williams KL, Clay-Falcone D, et al. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Human Molecular Genetics. 21: 2899-911. PMID 22454397 DOI: 10.1093/Hmg/Dds116 |
0.816 |
|
| 2011 |
Couthouis J, Hart MP, Shorter J, DeJesus-Hernandez M, Erion R, Oristano R, Liu AX, Ramos D, Jethava N, Hosangadi D, Epstein J, Chiang A, Diaz Z, Nakaya T, Ibrahim F, et al. A yeast functional screen predicts new candidate ALS disease genes. Proceedings of the National Academy of Sciences of the United States of America. 108: 20881-90. PMID 22065782 DOI: 10.1073/Pnas.1109434108 |
0.812 |
|
| 2011 |
Lee T, Li YR, Chesi A, Hart MP, Ramos D, Jethava N, Hosangadi D, Epstein J, Hodges B, Bonini NM, Gitler AD. Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology. 76: 2062-5. PMID 21562248 DOI: 10.1212/Wnl.0B013E31821F4447 |
0.778 |
|
| 2011 |
Sun Z, Diaz Z, Fang X, Hart MP, Chesi A, Shorter J, Gitler AD. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. Plos Biology. 9: e1000614. PMID 21541367 DOI: 10.1371/Journal.Pbio.1000614 |
0.793 |
|
| 2011 |
Konopka CA, Locke MN, Gallagher PS, Pham N, Hart MP, Walker CJ, Gitler AD, Gardner RG. A yeast model for polyalanine-expansion aggregation and toxicity. Molecular Biology of the Cell. 22: 1971-84. PMID 21508314 DOI: 10.1091/Mbc.E11-01-0037 |
0.571 |
|
| 2011 |
Armakola M, Hart MP, Gitler AD. TDP-43 toxicity in yeast. Methods (San Diego, Calif.). 53: 238-45. PMID 21115123 DOI: 10.1016/J.Ymeth.2010.11.006 |
0.719 |
|
| 2010 |
Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 466: 1069-75. PMID 20740007 DOI: 10.1038/Nature09320 |
0.709 |
|
| 2008 |
Erlichman JS, Hewitt A, Damon TL, Hart M, Kurascz J, Li A, Leiter JC. Inhibition of monocarboxylate transporter 2 in the retrotrapezoid nucleus in rats: a test of the astrocyte-neuron lactate-shuttle hypothesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 4888-96. PMID 18463242 DOI: 10.1523/Jneurosci.5430-07.2008 |
0.572 |
|
| Show low-probability matches. |